Supernus® Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 25 years- fueling the success of more than 10 widely recognized products. We are dedicated to the goal of improving the treatment of CNS disorders, including epilepsy, attention-deficit/hyperactivity disorder (ADHD), migraine and Parkinson’s disease.